MARKET

FBT

FBT

First Trust NYSE Arca Biotech ETF
NYSEARCA
154.42
-0.33
-0.21%
Closed 16:00 03/28 EDT
OPEN
154.89
PREV CLOSE
154.75
HIGH
155.24
LOW
154.10
VOLUME
18.83K
TURNOVER
0
52 WEEK HIGH
161.41
52 WEEK LOW
130.27
TOTAL ASSET
1.18B
YTD YIELD
2.79%
1D
5D
1M
3M
1Y
5Y
Should You Invest in the iShares Biotechnology ETF (IBB)?
NASDAQ · 1d ago
Weekly Report: what happened at FBT last week (0318-0322)?
Weekly Report · 4d ago
Should You Invest in the SPDR S&P Biotech ETF (XBI)?
NASDAQ · 4d ago
ARKG: Massive Potential, But Not Worth The Risk Yet For These 3 Reasons
ARK Genomic Revolution ETF warrants a hold rating due to underdeveloped technology, legal hurdles, and unresolved ethical dilemmas. The fund's performance has significantly underperformed the S&P 500 Index. ARKG has a relatively high expense ratio with no dividend yield and is concentrated in the healthcare sector.
Seeking Alpha · 4d ago
Taking Stock: Q2 2024 Equity Market Outlook
Seeking Alpha · 6d ago
Weekly Report: what happened at FBT last week (0311-0315)?
Weekly Report · 03/18 10:22
2024 Outlook: A New 'Super Boom'? Or Chop And Churn?
Seeking Alpha · 03/13 14:10
Weekly Report: what happened at FBT last week (0304-0308)?
Weekly Report · 03/11 10:20
More
Profile
Fund Name
First Trust NYSE Arca Biotech ETF
Inception Date
2006-06-19
Benchmark
NYSE Arca Biotechnology TR USD
Advisor Company
First Trust Advisors LP
Custodian
Bank of New York Mellon
Manager
Daniel Lindquist, Jon Erickson, David McGarel, Stan Ueland, Chris Peterson, Erik Russo, Roger Testin